anti-TET2 antibody product blog
Tags: Antibody; Polyclonal Antibody; TET2; anti-TET2 antibody;
The TET2 n/a (Catalog #MBS641423) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The TET2, NT (TET2, KIAA1546, Methylcytosine dioxygenase TET2) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s TET2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in Western Blot, ELISA
Dilution: ELISA: 1:1,000
Western Blot: 1:100-500. Researchers should empirically determine the suitability of the TET2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the TET2, NT (TET2, KIAA1546, Methylcytosine dioxygenase TET2) with the following immunoassay(s):
Western Blot (WB) (TET2 Antibody (N-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the TET2 antibody detected the TET2 protein (arrow).)
TET2 may catalyze the conversion of methylcytosine (5mC) to 5-hydroxymethylcytosine (hmC) (By similarity). Play an important role in the regulation of myelopoiesis.
Immunogen: TET2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 527-554 amino acids from the N-terminal region of human TET2. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TET2 are readily searchable from our website. Different antibodies against the same target such as TET2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.